Mary Gallagher
Pediatric Endocrinology · New York, NYNPI 1194792291
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,343 of the $9,105 with a category attached, or 80.7%. Sanofi-aventis U.S. LLC accounts for 79.9% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $7,255, 6.8 times the $1,068 reported in 2019.
Across 49 payments — averaging $185.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$7K
- Insulet Corporation$695
- Vertex$508
- Tandem Diabetes Care, Inc.$279
- Mannkind Corporation$136
- Sequel Med Tech, LLC$78
- plus $131 from 3 others
Across 59 payments — averaging $3065.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$77K
- Mannkind Corporation$48K
- Boehringer Ingelheim Pharma GmbH & Co.kg$28K
- Sanofi US Services Inc.$22K
- Boehringer Ingelheim France S.a.s.$4K
- Eli Lilly$394
- plus $384 from 1 others
What the payments were for
- Consulting fees$7,34381%
- Food & beverage$1,76119%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 6 | $7,278 |
| Insulet Corporation | 32 | $695 |
| Vertex | 1 | $508 |
| Tandem Diabetes Care, Inc. | 3 | $279 |
| Mannkind Corporation | 2 | $136 |
| Sequel Med Tech, LLC | 1 | $78 |
| Lilly USA, LLC | 2 | $74 |
| Medtronic | 1 | $30 |
| AbbVie | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$3,876
- Omnipod$281
- t-slim insulin pump$139
- t:slim X2 Insulin Pump with Control-IQ$139
- AFREZZA$118
How this compares
$9,105 in reported general payments places this provider in the 80th percentile of 138 pediatric endocrinology providers in New York.
Other pediatric endocrinology in New York
- Robert RapaportNew York$98K
- Christopher RomeroNew York$35K
- Vidhu ThakerNew York$33K
- Natasha LeibelNew York$24K
- Mabel YauNew York$19K
- Ilene FennoyNew York$19K
- Emily BreidbartNew York$18K
- Madeleine HarbisonNew York$12K
- Charles SklarNew York$12K
- Oksana LekarevNew York$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.